Mycobacterium marinum with different responses to second-generation tetracyclines

International Journal of Dermatology

Volumn 44, Issue 6, 2005, Pages 518-520

  Cummins, Deborah L ^a   Delacerda, Davi ^a   Tausk, Francisco A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DOXYCYCLINE; MINOCYCLINE; TETRACYCLINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; ENVIRONMENTAL EXPOSURE; EPITHELIUM HYPERPLASIA; FOLLOW UP; GRANULOMATOUS INFLAMMATION; HUMAN; HYPERKERATOSIS; KNEE; MALE; MYCOBACTERIUM MARINUM; PERSISTENT INFECTION; SKIN BIOPSY; SKIN DEFECT; SKIN INFECTION; SKIN INJURY; SKIN NODULE; TISSUE CULTURE; TREATMENT FAILURE; TREATMENT OUTCOME; WATER CONTAMINATION; WOUND INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; DOXYCYCLINE; HUMANS; HYPERPLASIA; MALE; MINOCYCLINE; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM MARINUM; SKIN;

EID: 20944436619     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02204.x     Document Type: Article

References (14)

1. Casal M, Casal MM. Multicenter study of incidence of Mycobacterium marinum in humans in Spain. Int J Tuberc Lung Dis 2001; 5: 197-199.
2. Edelstein H. Mycobacterium marinum skin infections. Report of 31 cases and review of the literature. Arch Intern Med 1994; 154: 1359-1364.
3. Hoyt RE, Bryant JE, Glessner SF, et al. M. marinum infections in a Chesapeake Bay community. Va Med 1989; 116: 467-470.
4. Joe L, Hall E. Mycobacterium marinum disease in Anne Arundel County: 1995 update. Md Med J 1995; 44: 1043-1046.
5. Zeligman I. Mycobacterium marinum granuloma. A disease acquired in the tributaries of Chesapeake Bay. Arch Dermatol 1972; 106: 26-31.
6. Ang P, Rattana-Apiromyakij N, Goh CL. Retrospective study of Mycobacterium marinum skin infections. Int J Dermatol 2000; 39: 343-347.
7. Edelstein H. Mycobacterium marinum skin infections. Report of 31 cases and review of the literature. Arch Intern Med 1994; 154: 1359-1364.
8. Weitzul S, Eichhorn PJ, Pandya AG. Nontuberculous mycobacterial infections of the skin. Dermatol Clin 2000; 18: 359-377, xi-xii.
9. Ena P, Sechi LA, Saccabusi S, et al. Rapid identification of cutaneous infections by nontubercular mycobacteria by polymerase chain reaction-restriction analysis length polymorphism of the hsp65 gene. Int J Dermatol 2001; 40: 495-499.
10. Aubry A, Jarlier V, Escolano S, et al. Antibiotic susceptibility pattern of Mycobacterium marinum. Antimicrob Agents Chemother 2000; 44: 3133-3136.
11. Rhomberg PR, Jones RN. In vitro activity of 11 antimicrobial agents, including gatifloxacin and GAR936, tested against clinical isolates of Mycobacterium marinum. Diagn Microbiol Infect Dis 2002; 42: 145-147.
12. Torres JR, Sands M, Sanders CV. In vitro sensitivity of Mycobacterium marinum to minocycline and doxycycline. Tubercle 1978; 59: 193-195.
13. Maibach H. Second-generation tetracyclines, a dermatologic overview: clinical uses and pharmacology. Cutis 1991; 48: 411-417.
14. Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol 1997; 133: 1224-1230.